Literature DB >> 17580335

Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA.

Yu-Chi Chou1, Mong-Liang Chen, Cheng-Po Hu, Ya-Ling Chen, Chin-Liew Chong, Yue-Lin Tsai, Tzu-Ling Liu, King-Song Jeng, Chungming Chang.   

Abstract

UNLABELLED: Transforming growth factor-beta1 (TGF-beta1) is a pleiotropic cytokine with pivotal roles in the regulation of cellular functions and immune responses. In this study, we found that TGF-beta1 was able to effectively suppress hepatitis B virus (HBV) replication. In the presence of TGF-beta1, the level of viral replicative intermediates was dramatically decreased, both in actively dividing cells and in confluent cells. At the same time, the levels of viral transcripts, core protein, and nucleocapsid were significantly diminished by TGF-beta1 treatment. Interestingly, the inhibitory activity of TGF-beta1 was associated with preferential reduction of the level of pregenomic RNA compared with pre-C mRNA. Further analysis indicated that TGF-beta1 might exert its antiviral effect primarily through reducing expression of the HBV core protein by transcriptional regulation instead of posttranscriptional modification.
CONCLUSION: TGF-beta1 may play a dual role in HBV infection, in the suppression of immune responses against viral infection and in the direct inhibition of viral replication, resulting in minimization of liver damage in patients with chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17580335     DOI: 10.1002/hep.21726

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Proteasomes regulate hepatitis B virus replication by degradation of viral core-related proteins in a two-step manner.

Authors:  Zi-Hua Zheng; Hui-Ying Yang; Lin Gu; Xiao-Mou Peng
Journal:  Virus Genes       Date:  2016-04-22       Impact factor: 2.332

Review 2.  Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.

Authors:  Xuefen Li; Xia Liu; Li Tian; Yu Chen
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

3.  HBV replication is significantly reduced by IL-6.

Authors:  Tzer-Min Kuo; Cheng-Po Hu; Ya-Ling Chen; Ming-Hsiang Hong; King-Song Jeng; Chun-Chin T Liang; Mong-Liang Chen; Chungming Chang
Journal:  J Biomed Sci       Date:  2009-04-20       Impact factor: 8.410

Review 4.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28

5.  Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.

Authors:  Ming-Hsiang Hong; Yu-Chi Chou; Yi-Chieh Wu; Kuen-Nan Tsai; Cheng-po Hu; King-Song Jeng; Mong-Liang Chen; Chungming Chang
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

6.  Dynamics of HBV cccDNA expression and transcription in different cell growth phase.

Authors:  Chin-Liew Chong; Mong-Liang Chen; Yi-Chieh Wu; Kuen-Nan Tsai; Chien-Chiao Huang; Cheng-Po Hu; King-Song Jeng; Yu-Chi Chou; Chungming Chang
Journal:  J Biomed Sci       Date:  2011-12-30       Impact factor: 8.410

7.  TGF-β and iron differently alter HBV replication in human hepatocytes through TGF-β/BMP signaling and cellular microRNA expression.

Authors:  Sun O Park; Mukesh Kumar; Sanjeev Gupta
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

8.  TGF-β suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex.

Authors:  Guoxin Liang; Guangyan Liu; Kouichi Kitamura; Zhe Wang; Sajeda Chowdhury; Ahasan Md Monjurul; Kousho Wakae; Miki Koura; Miyuki Shimadu; Kazuo Kinoshita; Masamichi Muramatsu
Journal:  PLoS Pathog       Date:  2015-04-02       Impact factor: 6.823

9.  CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study.

Authors:  I-Cheng Lee; Yi-Hsiang Huang; Chien-Wei Su; Yuan-Jen Wang; Teh-Ia Huo; Kuei-Chuan Lee; Han-Chieh Lin
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

10.  Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.

Authors:  Sebastian Malmström; Simon B Larsson; Charles Hannoun; Magnus Lindh
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.